Author: Alexis Opp

Polarean Highlights Role of Xenon MRI in Advancing Cardiopulmonary Clinical Trials

Posted on January 27, 2026January 30, 2026 by Alexis Opp

Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study

Posted on January 20, 2026January 27, 2026 by Alexis Opp

Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations

Posted on January 12, 2026January 27, 2026 by Alexis Opp

XENOVIEW® 3T coil passes Philips compatibility testing

Posted on December 1, 2025January 26, 2026 by Alexis Opp

Korean distributor agreement with DK Healthcare in South Korea

Posted on November 24, 2025November 24, 2025 by Alexis Opp

FDA expands XENOVIEW® indication to include children from six years of age

Posted on June 2, 2025June 2, 2025 by Alexis Opp

American Thoracic Society honors Dr. Bastiaan Driehuys for pioneering work in Xenon MRI

Posted on May 23, 2025May 23, 2025 by Alexis Opp

 

 

Philips and Polarean partner to bring advanced Xenon lung MRI to more children with chronic obstructive lung disease

Posted on May 16, 2025May 16, 2025 by Alexis Opp

Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum

Posted on May 15, 2025May 15, 2025 by Alexis Opp

Expansion of Xenon MRI imaging platform for pharma-sponsored research

Posted on March 10, 2025January 30, 2026 by Alexis Opp